Buy Crypto Markets Spot FuturesSKHYNIX Earn Event Center Rewards Hub

Vistagen Therapeutics, Inc. (VTGN)

NASDAQ

$0.24

$+0.00

(+0.89%)

Market Closed

Vistagen Therapeutics, Inc. (VTGN) Live Price Chart

Last updated: ⁦2026-07-22 22:37:00⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Key Market Data

Market Cap	$9.48M
Open	$0.24
High	$140.70
Low	$0.20
Previous Close	$0.23
Price Change	$+0.00
Percentage Change	+0.89%
Volume	223K

Vistagen Therapeutics, Inc. (VTGN) Stock Price Today

Vistagen Therapeutics, Inc. (VTGN) is currently trading at $0.24 as of 2026-07-22 22:36:00, reflecting a +0.89% move ($+0.00) from the previous close.

In the short term, the stock has returned -62.52% over the past four weeks. Over the last 12 months, Vistagen Therapeutics, Inc. has recorded a -90.67% price change, indicating a Weak performance relative to the broader market.

Vistagen Therapeutics, Inc. (VTGN) 7-Day Stock Price Changes

Over the past seven days, Vistagen Therapeutics, Inc. has traded within a short-term range shaped by market sentiment in the PHARMACEUTICAL PREPARATIONS sector. During this period, the stock moved from its previous closing price of $0.25 to the latest recorded price of $0.24, reflecting an intraday change of +0.89%. Daily movements highlight shifts in trading volume (222,874), investor positioning, and reactions to macroeconomic updates.

From a momentum standpoint, VTGN has delivered a -62.52% return over the past month and a -90.67% change in the last 12 months, indicating a Weak trend relative to its broader sector peers.

How to Buy Vistagen Therapeutics, Inc. (VTGN)

You can buy and trade VTGN on MEXC in three simple steps:

Step 1: Create and Verify Your MEXC Account

Sign up on MEXC and complete the required identity verification (KYC). This ensures full access to trading features and secure funding options.

Step 2: Deposit Funds Into Your Account

Choose your preferred payment method to add USDT or other supported assets to your MEXC wallet. Depositing crypto is the fastest way to get started.

Step 3: Search for VTGN and Execute Your Trade

Open the trading page, enter VTGN in the search bar, select the amount of VTGN you would like to purchase. Place a market order for instant execution or a limit order to buy at your target price.

What is Vistagen Therapeutics, Inc. (VTGN)?

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

Vistagen Therapeutics, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	41
Sector	PHARMACEUTICAL PREPARATIONS
Company Website	https://www.vistagen.com

Frequently Asked Questions (FAQ)

1.What is the current share price of Vistagen Therapeutics, Inc.?

The latest trading price for Vistagen Therapeutics, Inc. (Common Stock) is $ 0.24, compared with a previous closing price of $ 0.24. That means the stock has moved +0.89% so far today. Intraday price updates and recent trading activity for VTGN can be tracked on the live chart and quote section on this page.

2.Is Vistagen Therapeutics, Inc. stock going up or down?

Looking at recent performances, VTGN has returned -62.52% over the past month, -62.04% over the last six months and -90.67% over the past year. These figures capture share-price changes only, not the impact of dividends. Together they describe Weak price momentum for Vistagen Therapeutics, Inc. stock, but keep in mind that past returns do not guarantee future results.

3.Where does VTGN currently sit relative to its 52-week high and low?

In the most recent 52-week period, Vistagen Therapeutics, Inc. has traded between a low of $ 0.20 and a high of $ 5.14. This 52-week range helps show where today's share price sits relative to its recent highs and lows, and is often used by investors to judge stock volatility, potential support and resistance levels, and whether VTGN is currently nearer the top or the bottom of its one-year trading band.

4.How is Vistagen Therapeutics, Inc. classified by sector and industry?

Vistagen Therapeutics, Inc. is classified in the PHARMACEUTICAL PREPARATIONS sector. In practice, this means Vistagen Therapeutics, Inc. is grouped with other companies that serve similar end-markets and operate under comparable competitive and regulatory conditions. For investors, knowing VTGN’s sector helps with portfolio diversification, peer comparisons, and understanding how broader trends affecting the PHARMACEUTICAL PREPARATIONS sector could influence Vistagen Therapeutics, Inc.’s performance.

5.Where is Vistagen Therapeutics, Inc. listed and how large is it by market value?

Vistagen Therapeutics, Inc. is listed on the NASDAQ stock exchange in United States. Based on a market capitalization of $ 9.48M, the company is classified as a Small-cap stock. Market cap gives a quick sense of Vistagen Therapeutics, Inc.'s size and importance in the equity market and is often used by investors and index providers when constructing portfolios or benchmarks.

6.What does VTGN's EPS tell investors about its profitability?

Trailing-twelve-month EPS of $ -1.70 summarises how much profit Vistagen Therapeutics, Inc. has generated per share over the last year. Rising EPS over time can signal improving profitability or effective share repurchases, while flat or declining EPS may point to slower growth or margin pressure. EPS is a key input into valuation metrics such as P/E and is often monitored closely around earnings announcements.

7.How can I track Vistagen Therapeutics, Inc.'s financial performance over time?

To follow Vistagen Therapeutics, Inc.'s financial performance, investors typically review its quarterly and annual reports, which include detailed income statements, balance sheets and cash-flow statements. Combining these filings with key market data shown on this page—such as share price trends, P/E and dividend yield—provides a more complete view of how VTGN is performing and how the market is responding.

8.When is Vistagen Therapeutics, Inc. expected to report earnings?

Vistagen Therapeutics, Inc.'s next scheduled earnings release is currently expected on -- (the date may be updated by the company). Earnings announcements often act as important catalysts for VTGN, as they provide updated information on revenue, profitability and management's outlook.

9.What usually comes out in Vistagen Therapeutics, Inc.'s earnings reports?

Vistagen Therapeutics, Inc.'s earnings reports typically include headline figures such as revenue, net income and EPS, along with commentary on segment performance, margins, cash flow and guidance for future periods. Investors compare these results with market expectations and prior periods to assess whether VTGN is meeting, beating or missing expectations.

10.How can I stay informed about Vistagen Therapeutics, Inc.'s results and guidance?

You can stay up to date on Vistagen Therapeutics, Inc. by reviewing its quarterly earnings releases, listening to or reading transcripts of earnings calls, and following company news and filings. Pairing this fundamental information with the price and return data for VTGN on this page helps you see how new information is being reflected in the stock.

11.Does Vistagen Therapeutics, Inc. pay a regular cash dividend to its shareholders?

Vistagen Therapeutics, Inc. Non-paying. Based on the latest information, the stock has an indicated annual cash dividend of -- per share and a current dividend yield of 0 at the recent share price. Dividends are typically paid --, although the board can change the dividend policy at any time. Income-focused investors often monitor VTGN's dividend level, payment frequency and any announcements about future dividends when assessing the stock's appeal as a dividend-paying investment.

12.What are the current dividend yield and dividend payout ratio for VTGN?

Based on the latest earnings data, VTGN has a dividend yield of 0 and a dividend payout ratio of 0. The dividend yield shows how much cash return an investor receives from dividends each year relative to the current share price, helping assess whether Vistagen Therapeutics, Inc. is an attractive income stock. The dividend payout ratio measures what percentage of earnings Vistagen Therapeutics, Inc. distributes to shareholders as dividends versus how much it retains to reinvest in the business, which is an important indicator of dividend sustainability and room for future dividend growth.

13.What kind of business is Vistagen Therapeutics, Inc.?

Vistagen Therapeutics, Inc. is a publicly traded company in the PHARMACEUTICAL PREPARATIONS industry within the PHARMACEUTICAL PREPARATIONS sector. It generates revenue from products and services related to this core business area, and investors can find a detailed description of its operations, strategy and geographic exposure in the company's annual report and other regulatory filings.

14.How is VTGN valued in terms of P/E ratio and EPS?

Vistagen Therapeutics, Inc. currently trades at a price-to-earnings (P/E) ratio of --, based on trailing-twelve-month earnings per share (EPS) of $ -1.70. P/E is calculated by dividing the share price by EPS and shows how much investors are paying today for each unit of Vistagen Therapeutics, Inc.'s earnings. Comparing VTGN's P/E and EPS to those of other PHARMACEUTICAL PREPARATIONS companies can help investors judge whether its valuation looks rich or attractive.

Explore More US Stocks

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Union Pacific Corp.

UNP

Western Digital Corp.

WDC

Analog Devices, Inc.

ADI

Qualcomm Inc.

QCOM

Seagate Technology Holdings PLC

STX

Top Gainers

Browse today's leading gainers in the US stock market

PN Smart Energy Limited

Zhongchao Inc.

ZCMD

Lakewood-Amedex Biotherapeutics Inc.

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

BTC

ETH

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

VTGN-to-USD Calculator

Amount

VTGN

USD

1 VTGN = 0.237 USD